Tempus AI (NASDAQ:TEM) Trading 10.4% Higher

Tempus AI, Inc. (NASDAQ:TEM) was up 10.4% during mid-day trading on Thursday . The company traded as high as $60.00 and last traded at $59.31. Approximately 162,677 shares were traded during mid-day trading, a decline of 87% from the average daily volume of 1,205,353 shares. The stock had previously closed at $53.74.

Analyst Upgrades and Downgrades

TEM has been the subject of several research analyst reports. Needham & Company LLC restated a “buy” rating and set a $47.00 price target on shares of Tempus AI in a research report on Wednesday, August 7th. Piper Sandler began coverage on Tempus AI in a research report on Monday, August 12th. They issued a “neutral” rating and a $40.00 target price for the company. Longbow Research started coverage on shares of Tempus AI in a research report on Tuesday, July 9th. They set a “buy” rating and a $48.00 price target on the stock. Stifel Nicolaus started coverage on shares of Tempus AI in a report on Tuesday, July 9th. They set a “buy” rating and a $45.00 target price on the stock. Finally, Bank of America assumed coverage on shares of Tempus AI in a research note on Tuesday, July 9th. They issued a “buy” rating and a $41.00 price target for the company. One investment analyst has rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $45.56.

Tempus AI Stock Performance

The firm’s fifty day simple moving average is $45.49.

Tempus AI (NASDAQ:TEM) last posted its earnings results on Tuesday, August 6th. The company reported ($6.77) EPS for the quarter, missing the consensus estimate of ($4.41) by ($2.36). The company had revenue of $165.97 million during the quarter, compared to analysts’ expectations of $159.10 million. Research analysts forecast that Tempus AI, Inc. will post -6.51 EPS for the current year.

Hedge Funds Weigh In On Tempus AI

Hedge funds have recently added to or reduced their stakes in the stock. Sandia Investment Management LP acquired a new position in shares of Tempus AI in the 2nd quarter valued at $136,000. Northwestern University purchased a new stake in Tempus AI in the second quarter valued at $491,000. Squarepoint Ops LLC acquired a new position in Tempus AI in the second quarter valued at $633,000. WINTON GROUP Ltd purchased a new position in shares of Tempus AI during the second quarter worth about $634,000. Finally, Scientech Research LLC acquired a new stake in shares of Tempus AI during the second quarter worth about $756,000.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.